Kairbaan M Hodivala-Dilke

14PUBLICATIONS
94CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 19, 2026
Distinct migratory dendritic cell subsets cooperate to prime tissue-resident memory-like CD8⁺ T cells in mouse tumors.

|Mar 10, 2026
Advancing lung cancer therapy - leveraging cell biology to improve immunotherapy and anti-angiogenic strategies.

Jozafina Haj-Shomaly, Alejandro Castillo-Kauil, Carla Bloom

|Sep 15, 2025
Angiocrine and pericrine signaling: how endothelial cells and pericytes drive cancer progression and therapy resistance.

Alexander M Jordan, Rebecca J G Drake, Kairbaan M Hodivala-Dilke

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Oct 24, 2023
Effects of senescence on the tumour microenvironment and response to therapy.

Louise E Reynolds, Seynab Maallin, Scott Haston

|Oct 21, 2022
Primary tumor-derived systemic nANGPTL4 inhibits metastasis.

Corinne Hübers, Ashik Ahmed Abdul Pari, Denise Grieshober

Pageof 3

Frequent Collaborators

4 joint publications

Louise E Reynolds

4 joint publications

Rebecca J G Drake

3 joint publications

Alexander M Jordan

2 joint publications

Maddy Parsons